Business Strategy and Market Position Illumina's strategy revolves around maintaining its dominant position in the sequencing market while adapting to evolving customer needs and competitive ...

Illumina has begun rolling out its protein research platform, powered in part by tech from SomaLogic, which the DNA ...

Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease . Following early ...

NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform Findings in lung cancer show that CTCs can provide additional biomarkers not found in ctDNA from ...

Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf previous DNA sequencing projects.